RxDoctor Payments DataLook up a doctor →

Dennis Thompson, DO

Adult Medicine · Cleveland, TNNPI 1326151655

Payments from drug & device makers

$10,036in general payments, 2019–2025

Across 606 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$960
  • Lilly USA, LLC$911
  • AbbVie$788
  • Pfizer$695
  • Bayer$478
  • plus $4K from 40 others

What the payments were for

  • Food & beverage$10,031100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,036 in reported general payments places this provider in the 90th percentile of 22 adult medicine providers in Tennessee.

See all adult medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$181,844
Medicare patients
278
Services billed
5,804

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xultophy 100-3.6Insulin Degludec/Liraglutide63$159,653
JardianceEmpagliflozin146$159,019
OzempicSemaglutide77$98,878
EliquisApixaban86$86,737
Tresiba Flextouch U-200Insulin Degludec45$66,959
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$51,973
Soliqua 100-33Insulin Glargine/Lixisenatide29$48,125
FarxigaDapagliflozin Propanediol46$44,159
XareltoRivaroxaban41$41,886
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$25,129
TrulicityDulaglutide19$20,898
MyrbetriqMirabegron17$14,032
Novolog FlexpenInsulin Aspart23$13,204
SymbicortBudesonide/Formoterol Fumarate26$8,058
VascepaIcosapent Ethyl15$7,450

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskXultophy 100-3.6, Ozempic$1,850$258,531140 claims
Boehringer IngelheimJardiance$301$159,019146 claims
PfizerEliquis$695$86,73786 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$960$77,34699 claims
GSKTrelegy Ellipta$126$51,97346 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$286$48,12529 claims
Johnson & JohnsonXarelto$214$41,88641 claims
Lilly USA, LLCTrulicity$911$20,89819 claims
Astellas Pharma US IncMyrbetriq$132$14,03217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 22 adult medicine providers in Tennessee.

Other adult medicine in Cleveland

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →